Description
Position Summary:
ultrafocused – Work together to fearlessly uncover new possibilities
Ultragenyx is looking for a Director, Regional Launch Program Manager with a passion and creativity to develop great medicines for rare and ultra-rare diseases. The individual will be a self-starter with excellent project management skills and the ability to build strong rapport across functions. The successful candidate will be ready for a career defining experience and have the passion to drive a number of therapeutics for devastating diseases to final approval and launch.
This position will report to the Senior Director of Program and Portfolio Management and will be responsible for providing Program Management support to multiple program launch teams in a defined region. This role may potentially manage one or more programs and/or cross-functional initiatives, depending on the scope of a program within commercialization stages. In addition, this individual will actively support development of the department and tools/process across the portfolio.
Work Model:
Remote: Officially documented as working full-time from home, with travel to Ultragenyx's offices or other locations on occasion as needed.
Responsibilities:
- Develop and maintain comprehensive, cross-functional launch readiness plans, ensuring alignment across clinical, regulatory, commercial, medical affairs, supply chain, and market access teams.
- Establish launch governance structures, including escalation pathways, decision frameworks, and stakeholder communication models.
- Own end-to-end launch timeline development and execution, proactively identifying critical path dependencies and mitigating risks to ensure on-time, successful product launches.
- Lead development, implementation, and optimization of launch readiness tools, including integrated launch plans, risk registers, dashboards, and collaboration platforms.
- Drive preparation and execution of Launch Readiness Reviews (LRRs), ensuring readiness criteria are clearly defined, measurable, and consistently applied across programs.
- Facilitate cross-functional team meetings, ensuring clear agendas, actionable outcomes, accountability tracking, and effective issue resolution.
- Partner with regional and global stakeholders to ensure alignment of launch strategy, including adaptation of global plans to regional market needs.
- Monitor and report on key launch performance indicators (KPIs), providing actionable insights and recommendations to senior leadership.
- Identify, assess, and manage risks and opportunities, leading mitigation planning and contingency strategy development.
- Collaborate with commercial teams to ensure readiness across key domains including pricing, reimbursement, market access, distribution, and patient services.
- Serve as a key liaison between regional teams, program teams, and executive stakeholders to ensure transparency and alignment.
- Lead post-launch assessments and capture lessons learned to continuously improve launch excellence capabilities.
- Collaborate with other Regional Program Managers in the LATAM and EMEA regions to share and exchange ideas, strategies, and information.
- Collaborate with the Program Core Team Program Manager, Program Team Leader and Program Core team to ensure alignment of strategies and execution.
- Manage post-launch commercial and medical affairs operations, in collaborations with Global and Regional teams.
Requirements:
- Fluency in Japanese (written and spoken) is required, along with a strong understanding of Japanese culture and business practices. Business-level English communication skills are essential for effective collaboration with global stakeholders.
- Position will be located in Japan, in the Tokyo area.
- Required advanced degree with minimum of 15 years of industry experience
- At least 8-10 years equivalent multi-/ cross-functional leadership experience commercialization of products.
- Advanced level of science and clinical acumen. Experience working in genetic, rare diseases preferred
Similar jobs
Est. 200,000 USD
Why Join Us? Be a hero for our rare disease patients At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve…
Est. 140,000 USD
Why Join Us? Be a hero for our rare disease patients At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve…
Est. 150,000 GBP
Why Join Us? Be a hero for our rare disease patients At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve…
Est. 250,000 USD
About Us Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. It is Kardigan’s mission to develop multiple targeted treatme…
Est. 120,000 USD
Program Manager, Preclinical & Early Development Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines…
Est. 140,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 165,000 USD
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor…
Est. 120,000 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 250,000 USD
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments…
Est. 120,000 USD
Company Description Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in ca…
Est. 120,000 USD
Company Description Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in ca…
Est. 250,000 USD
About Us Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. It is Kardigan’s mission to develop multiple targeted treatme…
Est. 140,000 USD
About Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, ta…
Est. 165,000 USD
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor…
Est. 120,000 USD
COMPANY DESCRIPTION: A career here is life-enhancing. At Syner-G, we enable our people to build careers that impact positively on their quality of life. Through our expertise, insight, consulting and management skills, w…
Est. 250,000 USD
Position Summary What if... We could harness the power of Flagship’s scientific platforms and create novel treatment options that benefit more patients, sooner? Pioneering Medicines, an initiative of Flagship Pioneering,…
Est. 250,000 USD
Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically im…
Est. 250,000 USD
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor…
Est. 140,000 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 140,000 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 140,000 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 120,000 USD
Calyxo, Inc. is a medical device company headquartered in Pleasanton, California, USA. The company was founded in 2016 to address the profound need for improved kidney stone treatment. Kidney stone disease is a common, p…
Est. 120,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 140,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 140,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 140,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 120,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 120,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 140,000 USD
Beacon Biosignals is transforming precision medicine for the brain, from clinical development to clinical care. For Life Sciences partners, we offer the leading at-home EEG platform for clinical development of novel ther…
Est. 140,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…